Gait Recovery After Stroke
Launched by UNIVERSITY OF STRATHCLYDE · Jan 28, 2025
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The "Gait Recovery After Stroke" trial is studying how people recover their walking balance and stability after having a stroke. Researchers will use special wearable sensors to measure how well participants can stand evenly on both legs during the first six months after their stroke. They also want to understand how different factors, like the type of stroke and which side of the body is affected, impact this recovery process.
To join this study, participants need to be at least 18 years old and have experienced their first stroke, confirmed by a stroke specialist. They should also be stable enough to participate in rehabilitation and able to walk with some assistance. However, individuals with certain conditions, like severe skin issues, previous mild strokes, or diseases that affect walking, will not be eligible. While the trial is not recruiting yet, those who participate can expect to wear sensors that help track their progress as they work on their walking abilities. This research aims to improve understanding of stroke recovery and help develop better rehabilitation strategies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • aged 18 or older
- • diagnosis of a first occurrence of stroke by consultant stroke physician
- • Medically stable
- • referred for rehabilitation
- • functional ambulatory category of 1 and over
- Exclusion Criteria:
- • acute skin condition
- • transient ischemic stroke
- • comorbidities that may interfere with walking function, such as Parkinson's disease or lower limb amputation
- • severe communication impairments or delirium
About University Of Strathclyde
The University of Strathclyde is a leading research institution based in Glasgow, Scotland, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its robust academic resources and interdisciplinary expertise to drive impactful research initiatives. With a focus on improving patient outcomes and fostering collaboration between academia and industry, the University of Strathclyde is dedicated to conducting high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately contributing to the advancement of medical science and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Andrew Kerr, Ph.D
Principal Investigator
University of Strathclyde
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported